Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 123

1.

Conjunctivochalasis as a contributing factor for the development of ocular surface disease in medically treated glaucoma patients.

Kocabeyoglu S, Mocan MC, Irkec M, Orhan M, Karakaya J.

J Glaucoma. 2014 Jun-Jul;23(5):333-6. doi: 10.1097/IJG.0b013e3182741f32.

PMID:
23377585
2.

Topical glaucoma therapy and ocular surface disease: a prospective, controlled cohort study.

Saade CE, Lari HB, Berezina TL, Fechtner RD, Khouri AS.

Can J Ophthalmol. 2015 Apr;50(2):132-6. doi: 10.1016/j.jcjo.2014.11.006.

PMID:
25863853
3.

Ocular Surface Disease in Glaucoma: Effect of Polypharmacy and Preservatives.

Ramli N, Supramaniam G, Samsudin A, Juana A, Zahari M, Choo MM.

Optom Vis Sci. 2015 Sep;92(9):e222-6. doi: 10.1097/OPX.0000000000000542.

PMID:
25730335
4.

Prevalence of ocular surface complaints in patients with glaucoma using topical intraocular pressure-lowering medications.

Fechtner RD, Godfrey DG, Budenz D, Stewart JA, Stewart WC, Jasek MC.

Cornea. 2010 Jun;29(6):618-21. doi: 10.1097/ICO.0b013e3181c325b2.

PMID:
20386433
5.

New approach for conjunctivochalasis using an argon green laser.

Yang HS, Choi S.

Cornea. 2013 May;32(5):574-8. doi: 10.1097/ICO.0b013e318255eaaa.

PMID:
22929155
6.

Meibomian Gland Dysfunction in Patients Receiving Long-Term Glaucoma Medications.

Uzunosmanoglu E, Mocan MC, Kocabeyoglu S, Karakaya J, Irkec M.

Cornea. 2016 Aug;35(8):1112-6. doi: 10.1097/ICO.0000000000000838.

PMID:
27055218
7.

The influence of glaucoma medications on ocular surface disease in primary open-angle glaucoma patients with and without conjunctivochalasis.

Kocabeyoglu S, Mocan MC, Irkec M.

Acta Ophthalmol. 2014 Nov;92(7):e592-3. doi: 10.1111/aos.12425. Epub 2014 Apr 28. No abstract available.

8.

Delayed tear clearance in patients with conjunctivochalasis is associated with punctal occlusion.

Erdogan-Poyraz C, Mocan MC, Irkec M, Orhan M.

Cornea. 2007 Apr;26(3):290-3.

PMID:
17413955
9.

Evaluation of ocular surface disease in patients with glaucoma.

Mathews PM, Ramulu PY, Friedman DS, Utine CA, Akpek EK.

Ophthalmology. 2013 Nov;120(11):2241-8. doi: 10.1016/j.ophtha.2013.03.045. Epub 2013 May 25.

10.

The prevalence of ocular surface complaints in Brazilian patients with glaucoma or ocular hypertension.

Costa VP, Marcon IM, Galvão Filho RP, Malta RF.

Arq Bras Oftalmol. 2013 Jul-Aug;76(4):221-5.

11.

[Ocular surface in glaucoma patients with topical treatment].

Zemba M, Papadatu CA, Enache VE, Sârbu LN.

Oftalmologia. 2011;55(3):94-8. Romanian.

PMID:
22428298
12.

Children with dry eye type conditions may report less severe symptoms than adult patients.

Han SB, Yang HK, Hyon JY, Hwang JM.

Graefes Arch Clin Exp Ophthalmol. 2013 Mar;251(3):791-6. doi: 10.1007/s00417-012-2097-2. Epub 2012 Jul 12.

PMID:
22790310
13.

Dry eye syndrome-related quality of life in glaucoma patients.

Rossi GC, Tinelli C, Pasinetti GM, Milano G, Bianchi PE.

Eur J Ophthalmol. 2009 Jul-Aug;19(4):572-9.

PMID:
19551671
14.

Elevated tear interleukin-6 and interleukin-8 levels in patients with conjunctivochalasis.

Erdogan-Poyraz C, Mocan MC, Bozkurt B, Gariboglu S, Irkec M, Orhan M.

Cornea. 2009 Feb;28(2):189-93. doi: 10.1097/ICO.0b013e3181861d0c.

PMID:
19158563
15.

The impact of conjunctivochalasis on dry eye symptoms and signs.

Chhadva P, Alexander A, McClellan AL, McManus KT, Seiden B, Galor A.

Invest Ophthalmol Vis Sci. 2015 May;56(5):2867-71. doi: 10.1167/iovs.14-16337.

16.

Prevalence of ocular surface disease in glaucoma patients.

Leung EW, Medeiros FA, Weinreb RN.

J Glaucoma. 2008 Aug;17(5):350-5. doi: 10.1097/IJG.0b013e31815c5f4f.

PMID:
18703943
17.

Corneal and conjunctival sensitivity in patients with dry eye: the effect of topical cyclosporine therapy.

Toker E, Asfuroğlu E.

Cornea. 2010 Feb;29(2):133-40. doi: 10.1097/ICO.0b013e3181acf68d.

PMID:
19966564
18.

Prevalence of signs and symptoms of ocular surface disease in individuals treated and not treated with glaucoma medication.

Ghosh S, O'Hare F, Lamoureux E, Vajpayee RB, Crowston JG.

Clin Exp Ophthalmol. 2012 Sep-Oct;40(7):675-81. doi: 10.1111/j.1442-9071.2012.02781.x. Epub 2012 Jun 4.

PMID:
22394358
19.

Effects of laser in situ keratomileusis on tear production, clearance, and the ocular surface.

Battat L, Macri A, Dursun D, Pflugfelder SC.

Ophthalmology. 2001 Jul;108(7):1230-5.

PMID:
11425680
20.

Ocular surface and tear parameters in patients with chronic hepatitis C at initial stages of hepatic fibrosis.

Karaman Erdur S, Kulac Karadeniz D, Kocabora MS, Ozsutcu M, Gulkilik IG, Demirci G, Eliacik M.

Eye Contact Lens. 2015 Mar;41(2):117-20. doi: 10.1097/ICL.0000000000000079.

PMID:
25503914

Supplemental Content

Support Center